CoChat

Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson’s disease: a pilot randomised controlled trial

Open access
Kratz, Elisabeth, Scheffer, Judith, Volc, Dieter, Seebacher, Barbara · 2025 · BMC Neurology

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index; 25 of the 62 sources its claims cite were checked for support.

Abstract

LSVT®LOUD is an intensive speech therapy targeting voice amplitude, incorporating proprioceptive feedback and auditory-vocal self-monitoring, delivered through 16 one-hour sessions over a month with a high-effort approach. This study aimed to investigate preliminary effects of LSVT®LOUD teletherapy (LSVT®LOUD-tele) in comparison to traditional face-to-face LSVT®LOUD therapy (LSVT®LOUD-FTF) in people with PD and hypokinetic dysarthria, and to assess the usability of the LSVT®LOUD-tele software and the feasibility of a full-scale randomised controlled trial (RCT). Using a pilot RCT, 20 people with PD and hypokinetic dysarthria were assigned to either LSVT®LOUD-tele or LSVT®LOUD-FTF, receiving 60-min sessions 4x/week for 4 weeks, along with home-based practice maintaining the same intensity and frequency in both conditions. Primary outcome was voice loudness (sound pressure levels [SPL]). Secondary outcomes included voice handicap, dysarthria-related QoL, HRQoL, and depression, assessed at baseline and post-intervention. The feasibility of conducting a full-scale RCT based on predetermined criteria (33% recruitment rate, 85% retention rate, 75% adherence rate, and high intervention safety) and the usability of the LSVT®LOUD-tele software were assessed post-intervention. Nineteen participants completed the study (10 women). The LSVT®LOUD-FTF group showed improvements in vowel ‘Ah’ and ‘high-pitched A’ SPLs (Hedge’s g = 1.416 and 0.826), while both groups showed increases in ‘low-pitched A’ and good quality loud voice SPLs (g = 0.148; g = 0.211). No changes were observed in everyday phrases SPL (g = 0.167) for either intervention, and both groups showed improvements in text reading (g = 0.436) and conversation SPLs (g = 0.345). Subjective voice handicap improved in both groups (eta squared [η2] = 0.259), while only LSVT®LOUD brought improvement to total dysarthria-related QoL (η2 = 0.747). HRQoL improvements were noted in activities of daily living, cognition, and bodily discomfort domains after LSVT®LOUD-FTF, and in communication after LSVT®LOUD-tele (η2 = 0.054–0.386). LSVT®LOUD-FTF led to small improvements in depression, with no significant differences noted between groups. Good-to-excellent usability of LSVT®LOUD-tele was observed, and the feasibility of a full-scale RCT was supported by high overall recruitment, retention, and adherence rates, with no adverse events reported. Both LSVT®LOUD-tele and LSVT®LOUD-FTF appear effective for people with PD and hypokinetic dysarthria, and the feasibility of a full-scale RCT was confirmed. Larger studies are needed to validate these findings. German Clinical Trials Register, DRKS00027825 . Registered on 13.01.2022.

Overview

CoChat Summary

TL;DR

In this pilot RCT, both online LSVT®LOUD teletherapy and face-to-face LSVT®LOUD improved some voice loudness and quality-of-life outcomes in people with Parkinson’s disease and hypokinetic dysarthria, with no adverse events. The authors conclude that a full-scale RCT is feasible and that LSVT®LOUD-tele software had good-to-excellent usability.

Key findings

  • Nineteen of 20 randomised participants completed the study (10 women; median age 70.3 years, range 51.2–77.3). LSVT®LOUD-FTF improved vowel ‘Ah’ and ‘high-pitched A’ SPLs (Hedge’s g = 1.416 and 0.826), while both groups improved ‘low-pitched A’ and good quality loud voice SPLs (g = 0.148; g = 0.211).
  • Neither group changed everyday phrases SPL (g = 0.167), but both improved text reading (g = 0.436) and conversation SPLs (g = 0.345). Only three LSVT®LOUD-tele and two LSVT®LOUD-FTF participants achieved a clinically significant ≥ 4.5 dB improvement in conversation SPL.
  • Subjective voice handicap improved in both groups (η² = 0.259); total dysarthria-related QoL improved in the LSVT®LOUD-FTF group (η² = 0.747). HRQoL improved in activities of daily living, cognition, and bodily discomfort after LSVT®LOUD-FTF, and in communication after LSVT®LOUD-tele (η² = 0.054–0.386).
  • Feasibility criteria were met: recruitment 39.2% (95% CI 25.8–53.9), retention 95% (95% CI 75.1–99.9), supervised adherence 99.1% (95% CI 68.7–99.6), home-based adherence 100% (95% CI 75.9–100), and no adverse events. TUQ usability total was median 6.2 (range 5.0–7.0).

Methods

  • Non-blinded pilot RCT conducted in Vienna, Austria, from 01.02.2022–08.08.2022. Twenty people with PD and hypokinetic dysarthria were randomised 1:1 to LSVT®LOUD-tele or LSVT®LOUD-FTF; 19 completed.
  • Both groups received 60-min sessions 4×/week for 4 weeks plus home practice, with the same LSVT®LOUD principles and intensity; delivery differed by online client-version LSVT®Coach versus face-to-face professional-version LSVT®Coach.
  • Primary outcome was voice loudness (SPL) across vocal tasks. Secondary outcomes included VHI, QOL-DyS, PDQ-39, BDI-II, feasibility criteria, and TUQ usability. Analysis used Shapiro–Wilk tests, Hedges’ g, non-parametric η², and Wilson score confidence intervals.

Limitations

  • The paper states the primary limitation is the small sample size, with intended enrolment of 30 not achieved; the same therapist delivered and assessed the intervention, preventing blinding; MMST limitations were not considered; the QOL-Dys validation study included only 6 people with PD; and exclusions limit generalisability to more severe PD, mild cognitive impairment, relevant comorbidities, and non-PD auditory/laryngeal pathologies.
  • Evident from the text: this is a pilot study without a formal sample size calculation, and outcomes were assessed only at baseline and post-intervention, with no longer-term follow-up reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12883-025-04161-0

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Professional LSVT®Coach version interface. Maximum sustained ‘Ahs’ (A), ‘high-pitched Ahs’ (B), ‘low-pitched Ahs’ (C), phrases (D), hierarchical training (E), conversation training instructions (F), entering targets for the client (G), and selection of daily phrases (H)
Fig. 1 Professional LSVT®Coach version interface. Maximum sustained ‘Ahs’ (A), ‘high-pitched Ahs’ (B), ‘low-pitched Ahs’ (C), phrases (D), hierarchical training (E), conversation training instructions (F), entering targets for the client (G), and selection of daily phrases (H)CC BY-NC-ND · PubMed Central
Fig. 2 CONSORT flow diagram, LSVT: Lee Silverman Voice Treatment
Fig. 2 CONSORT flow diagram, LSVT: Lee Silverman Voice TreatmentCC BY-NC-ND · PubMed Central
Fig. 3 Changes in the patients’ perceptions of their voice handicap. Violins show ranges, dotted lines represent 25th and 75th percentiles and dashed lines medians in LSVT®LOUD-tele and LSVT®LOUD groups respectively, for patients’ perceptions of their voice handicap. BL: baseline; LSVT: Lee Silverman Voice Treatment; PI: post-intervention
Fig. 3 Changes in the patients’ perceptions of their voice handicap. Violins show ranges, dotted lines represent 25th and 75th percentiles and dashed lines medians in LSVT®LOUD-tele and LSVT®LOUD groups respectively, for patients’ perceptions of their voice handicap. BL: baseline; LSVT: Lee Silverman Voice Treatment; PI: post-interventionCC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

20 Valid · 1 Not valid · 26 Not checked · 63 Own results and interpretations

33 more claims

Create a free account to see all 110 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 47
  • It may state two separate claims as one. 43
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 59 references

Research works printed but not linked: 2

  1. Schrader V, Schöttker-Könniger T, Beushausen U. Validierung der deutschen Version des „Quality of life in the dysarthric speaker“ - ein Selbsteinschätzungsbogen zur Erfassung der kommunikationsbezogenen Lebensqualität von PatientInnen mit einer Dysarthrie Logos Interdisziplinär. 2019;4:244–57. https://doi.org/10.7345/prolog-1904244. · doi:10.7345/prolog-1904244
  2. Tomczak M, Tomczak E. The need to report effect size estimates revisited. An overview of some recommended measures of effect size. Trends Sport Sci. 2014;1(21):19–55.

Metadata

Authors
Kratz, E., Scheffer, J., Volc, D., & Seebacher, B.
Affiliations
  • Universität für Weiterbildung Krems (AT)
  • Innsbruck Medical University (AT)
Corresponding author
Seebacher, Barbara
Venue
BMC Neurology
Published
2025-04-26
Volume
25
Issue
1
Pages
183-183
ISSN
1471-2377 (ISSN-L)
OpenAlex
W4409834762
Cited by
5
References
59
Citations by year
2026: 4 · 2025: 1
FWCI
4.05
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Neurology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Health Professions › Speech and Hearing › Voice and Speech Disorders
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Health Professions › Speech and Hearing › Dysphagia Assessment and Management
Keywords
Parkinson's disease, LSVT LOUD, external beam radiotherapy, hypokinetic dysarthria, vocal intensity, sound pressure level, voice handicap, home-based practice, speech therapy, feasibility, software usability, depression, proprioceptive feedback, activities of daily living, cognitive function, physiological function
MeSH terms
Aged, Dysarthria, Female, Humans, Male, Middle Aged, Parkinson Disease, Pilot Projects, Speech Therapy, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson’s disease: a pilot randomised controlled trial. https://app.cochat.ai/papers/10.1186/s12883-025-04161-0
The paper
Kratz, E., Scheffer, J., Volc, D., & Seebacher, B. (2025). Comparing face-to-face and online LSVT®LOUD speech training using LSVT®Coach in patients with Parkinson’s disease: a pilot randomised controlled trial. BMC Neurology. https://doi.org/10.1186/s12883-025-04161-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.